Operational Research for Cryptococcal antigen screening to improve ART survival

Dates

Start Date: 06/01/2012
End Date: 05/31/2016

This will be a phased-in, randomized trial design to evaluate the implementation of CRAG screening and pre-emptive antifungal therapy of HIV-infected persons entering ART outpatient treatment. Those who are ART eligible with a CD4=100 cells/L will have a serum CRAG performed by lateral flow assay. Those who are CRAG positive and asymptomatic will be treated with high dose fluconazole. After 6 months survival and cryptococcal meningitis free survival will be compared between those who are CRAG+ and CRAG negative.

Kampala, Uganda
«

January 2023

»
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
·
·
·
·

Projects

Nutrition Innovation Lab

"Poshan", which means good nutrition in Nepali is ongoing research that involves two interlinked large-scale research studies...

Read More

Mpilonhle

Mpilonhle brings multi-dimensional services to adolescents in rural South Africa. Its objective is to reduce the very high...

Read More

Building an Enabling Environment for Vaccines in India...

This project, now in its second phase, aims to create an enabling environment for vaccines in India and contribute to...

Read More

Identification and Enumeration of Pathogens in Drinking...

CWH researchers are using polymerase chain reaction and mass spectrometry technologies to develop a microbial isolation and...

Read More